Skip to main navigation Skip to search Skip to main content

Pancreatitis and pancreatic cancer risk: A pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)

  • E. J. Duell
  • , E. Lucenteforte
  • , S. H. Olson
  • , P. M. Bracci
  • , D. Li
  • , H. A. Risch
  • , D. T. Silverman
  • , B. T. Ji
  • , S. Gallinger
  • , E. A. Holly
  • , E. H. Fontham
  • , P. Maisonneuve
  • , H. B. Bueno-de-Mesquita
  • , P. Ghadirian
  • , R. C. Kurtz
  • , E. Ludwig
  • , H. Yu
  • , A. B. Lowenfels
  • , D. Seminara
  • , G. M. Petersen
  • C. La Vecchia, P. Boffetta
  • Institute Catala Oncologia
  • IRCCS Istituto di ricerche farmacologiche Mario Negri - Milano, Bergamo, Ranica
  • University of Florence
  • Memorial Sloan-Kettering Cancer Center
  • University of California at San Francisco
  • University of Texas MD Anderson Cancer Center
  • Yale University
  • National Institutes of Health
  • University of Toronto
  • Louisiana State University Health Sciences Center
  • IRCCS Istituto Europeo di Oncologia - Milano
  • National Institute of Public Health and the Environment
  • Utrecht University
  • Centre Hospitalier de L'Universite de Montreal
  • University of Hawai'i at Mānoa
  • New York Medical College
  • Mayo Clinic Rochester, MN
  • University of Milan

Research output: Contribution to journalArticlepeer-review

219 Scopus citations

Abstract

Background: Pancreatitis is a known risk factor for pancreatic cancer; however, an unknown fraction of the disease is thought to be a consequence of tumor-related duct obstruction. Patients and methods: A pooled analysis of a history of pancreatitis and risk of pancreatic cancer was carried out considering the time interval between diagnoses and potential modification by covariates. Adjusted pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from 10 case-control studies (5048 cases of ductal pancreatic adenocarcinoma and 10 947 controls) taking part in the International Pancreatic Cancer Case-Control Consortium (PanC4). Results: The association between pancreatitis and pancreatic cancer was nearly three-fold at intervals of >2 years between diagnoses (OR: 2.71, 95% CI: 1.96-3.74) and much stronger at intervals of ≤2 years (OR: 13.56, 95% CI: 8.72-21.90) probably reflecting a combination of reverse causation and antecedent misdiagnosis of pancreas cancer as pancreatitis. The younger (<65 years) pancreatic cancer cases showed stronger associations with previous (>2 years) pancreatitis (OR: 3.91, 95% CI: 2.53-6.04) than the older (≥65 years) cases (OR: 1.68, 95% CI: 1.02-2.76; P value for interaction: 0.006). Conclusions: Despite a moderately strong association between pancreatitis (diagnosed before >2 years) and pancreatic cancer, the population attributable fraction was estimated at 1.34% (95% CI: 0.612-2.07%), suggesting that a relatively small proportion of pancreatic cancer might be avoided if pancreatitis could be prevented.

Original languageEnglish
Pages (from-to)2964-2970
Number of pages7
JournalAnnals of Oncology
Volume23
Issue number11
DOIs
StatePublished - Nov 2012

Keywords

  • Case-control studies
  • Pancreatic cancer
  • Pancreatitis
  • Pooled analysis
  • Risk factors

Fingerprint

Dive into the research topics of 'Pancreatitis and pancreatic cancer risk: A pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)'. Together they form a unique fingerprint.

Cite this